IBEX

Value Q1, 25Q2, 25Q3, 25 TTM Total revenue 151.18 M164.22 M164.41 M 626.95 M Gross profit 44.6 M47.59 M48.79 M 187.25 M Operating expenses 137.48 M148.93 M148.25 M 569.54 M Selling/general/admin expenses 26.52 M27.55 M27.47 M 111.3 M Research & development ——— — Operating income 13.7 M15.29 M16.16 M 57.4 M Non-Operating Income, Total 30 K59 K62 K 180 K Interest expense, net of interest capitalized 217 K248 K249 K 1.16 M Non-Operating Income, excl. Interest Expenses -187 K-189 K-187 K -982 K Unusual income/expense ——— — Pretax income 13.51 M15.1 M15.97 M 56.42 M Equity in earnings 358 K359 K421 K 1.46 M Taxes 1.47 M2.88 M2.64 M 9.24 M Non-controlling/minority interest ——— — After tax other income/expense ——— — Net income before discontinued operations 12.04 M12.22 M13.32 M 47.18 M Discontinued operations ——— — Net income 12.04 M12.22 M13.32 M 47.18 M Dilution adjustment ——— — Preferred dividends ——— — Diluted net income available to common stockholders 12.04 M12.22 M13.32 M 47.18 M Basic earnings per share (Basic EPS) 0.90.910.99 3.46 Diluted earnings per share (Diluted EPS) 0.820.830.89 3.17 Average basic shares outstanding 13.36 M13.47 M13.45 M — Diluted shares outstanding 14.61 M14.74 M14.99 M — EBITDA 18.08 M20.04 M21.33 M 75.95 M EBIT 13.7 M15.29 M16.16 M 57.4 M Cost of revenue 106.58 M116.63 M115.61 M 439.69 M Other cost of goods sold 106.58 M116.63 M115.61 M 439.69 M Depreciation & amortization (cash flow) 4.38 M4.75 M5.17 M 18.55 M